QSant™ is a convenient, noninvasive, urine-based test that supports early detection of kidney rejection risk. By providing an actionable, individual risk score, it can empower clinicians to personalize care.
15 to 40%
of kidney transplants result in rejection
of kidney transplants every year are
re-transplants in patients with graft loss
QSant Clinical Validation Papers
Clinical validation of a non-invasive, spot urine-based transplant rejection test that provides indication of risk of rejection earlier than standard-of-care tests.
DOWNLOAD STM PAPER
PUBLISHED: 18 MARCH 2020
Development, validation, and clinical utility of a urinary Q-Score for the detection of acute rejection in adult and pediatric renal transplant patients
DOWNLOAD MDPI PAPER
PUBLISHED: 22 JULY 2020